Ten years after the first report, the Institute of Medicine has published a new study on the quality of cancer care in the United States, forced, according to experts, because the situation is far from improving. To better understand this work, we have to contextualize it in the United States, where they have serious problems of access to cancer care, coordination between professionals and exaggerated costs of clinical processes.
On the other hand, cancer care in our country is, obviously, more accessible and more coordinated than the United States, but nevertheless you will agree with me that we lack, by contrast, the evaluation and analytical capacity of Americans, and for this reason I believe that the findings presented in this report should teach us something with the intention of overcoming our own inefficiencies, because we do have them.
On the other hand, cancer care in our country is, obviously, more accessible and more coordinated than the United States, but nevertheless you will agree with me that we lack, by contrast, the evaluation and analytical capacity of Americans, and for this reason I believe that the findings presented in this report should teach us something with the intention of overcoming our own inefficiencies, because we do have them.
The IOM expert committee concluded that the model of cancer care in America is in crisis, mainly due to three factors: a) the clinical process too often does not focus on the patients’ preferences, b) many patients only receive palliative care at the end of life, and c) clinical decisions too often are not based on evidence.